Abstract:As we celebrate the 15th anniversary of Frontiers in Cellular Neuroscience, it is an opportune moment to reflect on the pivotal research contributions that have shaped our understanding of glial cells in schizophrenia and related disorders. Over the past decade and a half, this journal has been at the forefront of unveiling the complex roles that glial cells, particularly microglia and astrocytes, play in the pathophysiology of mental illnesses.The Intricate Dance of Microglia and Neurons in SchizophreniaHartmann et al. delve into the interactions between microglia and neurons in schizophrenia. Their comprehensive review highlights how microglia, the brain's resident immune cells, engage in a delicate balance of neuroprotection and neuroinflammation, which can be disrupted in schizophrenia. The study underscores the dual role of microglia in either exacerbating or mitigating neuronal damage, depending on their states (1). The authors argue that therapeutic strategies targeting specific microglial reaction states could offer new avenues for treating schizophrenia.Astrocytes: The Unsung Heroes of Brain HealthAstrocytes, another type of glial cell, have also been spotlighted for their crucial role in maintaining brain homeostasis and their involvement in mental disorders. While review articles provide a detailed account of how astrocytes contribute to the pathophysiology of schizophrenia (2), and discuss the astrocytic regulation of neurotransmitter systems, blood-brain barrier integrity, and synaptic function, all of which are often disrupted in schizophrenia (3, 4), Ling Yan et al. have further elucidated the heterogeneity of astrocytes and their distinct roles in various central nervous system (CNS) regions and pathological states, emphasizing the importance of these cells in both health and disease contexts.The Impact of Environmental Stressors: High Altitude and NeuroinflammationIn addition to genetic and molecular factors, environmental stressors such as high altitude have been shown to exacerbate microglial and astrocyte reactions, a common feature in many neurological disorders, including schizophrenia. Liu et al.'s study on the effects of high altitude on traumatic brain injury (TBI) reveals that hypoxic conditions can significantly worsen neuroinflammatory responses. The research demonstrates that L-serine, an endogenous amino acid, can mitigate these effects by modulating microglial activation through the NFAT1 pathway. This finding not only sheds light on the potential for L-serine as a neuroprotective agent but also underscores the broader implications of environmental factors on brain health.Innovative Approaches to Schizophrenia TreatmentSinger et al. explored the inhibition of astrocytic glycine transporter-1 (GlyT1) as a potential therapeutic approach for ameliorating NMDA receptor hypofunction in schizophrenia. The authors discuss the dual nature of GlyT1 inhibition, considering both its potential benefits and drawbacks. Their research suggests that while inhibiting GlyT1 may enhance N-methyl-D-aspartate (NMDA) receptor function and improve cognitive deficits in schizophrenia, careful consideration of the associated risks is essential. This study highlights the complexity of targeting astrocytic functions for therapeutic purposes and underscores the need for nuanced approaches in developing effective treatments.The insights gained from these studies highlight the multifaceted roles of glial cells in brain health and disease. As we look forward to the next decade of Frontiers in Cellular Neuroscience, several promising research directions emerge. (i) Microglial Modulation: Developing therapies that can precisely modulate microglial activation states to promote neuroprotection while minimizing neuroinflammation. (ii) Targeting Astrocyte Functions: Exploring astrocyte-targeted therapies to restore neurotransmitter balance and synaptic function in schizophrenia. (iii) Environmental Considerations: Investigating the impact of environmental stressors on glial cell function and developing strategies to mitigate their adverse effects. (iv) GlyT1 Inhibition: Further examining the therapeutic potential and risks of inhibiting astrocytic glycine transporter-1 to enhance NMDA receptor function in schizophrenia. In conclusion, the past 15 years have seen remarkable advancements in our understanding of glial cells and their roles in schizophrenia and related disorders. The continued exploration of these cellular players holds great promise for developing more effective treatments and improving the lives of those affected by these debilitating conditions.

Major depressive disorder and anxiety disorders from the glial perspective: Etiological mechanisms, intervention and monitoring

An astroglial basis of major depressive disorder: Molecular, Cellular, and Circuit Features

Microglial glutaminase 1 mediates chronic restraint stress-induced depression-like behaviors and synaptic damages

Glia mechanisms in mood regulation: a novel model of mood disorders

Role of Glial Cells in Neuronal Function, Mood Disorders, and Drug Addiction

Noteworthy perspectives on microglia in neuropsychiatric disorders

Putative role of glial cells in treatment resistance depression: An updated critical literation review and evaluation of single-nuclei transcriptomics data

Microglia in depression: current perspectives

Prefrontal cortex astrocytes in major depressive disorder: exploring pathogenic mechanisms and potential therapeutic targets

Neurodevelopmental and Neuropsychiatric Disorders

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments

Glial biomarkers in human central nervous system disease

Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression

Astroglia in the Vulnerability to and Maintenance of Stress-Mediated Neuropathology and Depression

Editorial: 15 years of Frontiers in Cellular Neuroscience: the role of glial cells in schizophrenia and other related disorders

Emerging Microglial Therapies and Targets in Clinical Trial

Consequences on Behavior and Potential as Treatment Target

Common Cellular and Molecular Mechanisms and Interactions Between Microglial Activation and Aberrant Neuroplasticity in Depression

Role of glia in delirium: proposed mechanisms and translational implications

Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities

Glia Signaling and Brain Microenvironment in Migraine